StockData
Quantum Biopharma Ltd. logo

Quantum Biopharma Ltd. (QNTM) stock

QNTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026Score 1/30
$1.59+0.15 (+10.42%)

Close on Nov 17, 2026Market cap $6.18MP/E –Yield –

Quantum Biopharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Quantum Biopharma's enterprise value was $308.86K on Feb 27, 2026, against -$4.26M a year earlier. Over the last 5 years it ranged from -$22.61M to $44.54M, with a median of $3.56M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Feb 27, 2026$308.86K-95.4%
2025Dec 31, 2025$6.71M–
2024Dec 31, 2024-$1.82M-109.8%
2023Dec 29, 2023$18.66M–
2022Dec 30, 2022-$7.70M–
2021Dec 31, 2021-$5.24M-203.8%
2020Dec 31, 2020$5.04M-68.8%
2019Dec 31, 2019$16.17M–

More Quantum Biopharma figures

See a number that looks wrong?